Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Recognise an acutely provoked seizure related to alcohol or drugs, treat immediate threats and withdrawal safely, and avoid mislabelling a reversible toxic presentation as chronic epilepsy.
An acute symptomatic seizure occurs in close temporal association with a systemic or brain insult. Relevant exposures include alcohol withdrawal, intoxication with stimulants or antidepressants, abrupt withdrawal of benzodiazepines or other sedatives, medication toxicity, recreational drugs and interactions that lower seizure threshold. Establish what actually happened: obtain a witness account, duration, onset, focal features, recovery and injury; distinguish epileptic convulsions from syncope, dystonia, tremor and functional attacks. Then construct a timeline of last alcohol intake, usual daily amount, recent reduction, prescribed and non-prescribed substances, dose changes, adherence, access to modified-release preparations and deliberate self-harm. A previous label of alcohol-related seizure must not suppress a fresh search for hypoglycaemia, intracranial bleeding, infection, electrolyte disturbance or epilepsy.
Alcohol withdrawal reflects reduced inhibitory GABA activity and unopposed excitation after adaptation to sustained exposure. Tremor, sweating, anxiety, nausea, tachycardia and insomnia may precede seizures; hallucinations and
A marked reduction after sustained heavy alcohol exposure can provoke generalised seizures, often alongside tremor, sweating, anxiety, insomnia and other features of escalating withdrawal.
Abrupt cessation of benzodiazepines or other inhibitory sedatives removes adapted inhibitory signalling and may cause seizures, agitation and autonomic instability, particularly after prolonged exposure.
Stimulants, antidepressants, tramadol, isoniazid and novel psychoactive substances lower seizure threshold through differing mechanisms; formulation, timing, interactions and co-ingestants guide toxicological assessment.
Hypoglycaemia, electrolyte disturbance, liver disease, infection, head trauma and intracranial bleeding commonly coexist with harmful substance use and may be the actual provoking insult.
Sustained alcohol or sedative exposure strengthens inhibitory effects and promotes compensatory excitatory signalling, allowing the brain to function despite continued drug presence.
Withdrawal removes the inhibitory agent before compensatory excitation subsides, producing network hyperexcitability, autonomic activation and a lowered threshold for synchronised cortical discharge.
Proconvulsant drugs may enhance monoamines, block inhibitory signalling, impair ion channels or cause metabolic injury, allowing abnormal cortical activity to recruit bilateral convulsive networks.
Generalised convulsions after recent marked reduction or cessation, accompanied by autonomic withdrawal features and a credible dependence history, support but do not prove alcohol withdrawal.
Fluctuating confusion, severe agitation, hallucinations, fever and marked autonomic overactivity after alcohol reduction indicate a medical emergency with substantial morbidity and mortality.
Agitation, mydriasis, diaphoresis, tachycardia, hypertension and hyperthermia with seizures suggest stimulant or other sympathomimetic toxicity and demand rapid cooling and toxicology support.
Confusion, gait or oculomotor abnormality in a malnourished dependent drinker may be incomplete Wernicke encephalopathy; absence of the classic triad does not make it safe to withhold parenteral thiamine.
Abrupt cessation of regular benzodiazepines or related sedatives can cause anxiety, tremor, perceptual symptoms and seizures, sometimes later than alcohol withdrawal because drug half-lives differ.
Previous unprovoked events, focal onset, epileptiform EEG findings or a structural lesion suggest an enduring epileptic tendency rather than a purely time-limited toxic seizure.
Presyncope, pallor, a situational trigger and rapid recovery favour cerebral hypoperfusion; brief jerks may accompany syncope and should not automatically be labelled epilepsy.
A prolonged fluctuating event, asynchronous movement and preserved interaction can support a functional seizure, ideally confirmed through specialist semiology or capture of a typical event.
Sustained tremor, dystonia or agitation may look convulsive but lacks the stereotyped tonic–clonic sequence and post-event recovery pattern of a generalised epileptic seizure.
Focal onset, persistent lateralising signs, meningism, disproportionate headache, anticoagulation or significant head trauma should redirect assessment towards structural bleeding, stroke, infection or another neurological lesion.
Repeated or prolonged seizures can cause hypoxia, aspiration, acidosis and cardiorespiratory failure, requiring protocol-led escalation and simultaneous correction of the provoking mechanism.
Sudden loss of awareness causes head injury, fractures, burns and drowning risk, while vomiting or depressed consciousness increases aspiration and airway obstruction.
Continuing withdrawal can progress to hallucinations, delirium, fever and profound autonomic instability, creating risks separate from the seizure itself.
Incorrectly labelling a provoked event as chronic epilepsy can expose the person to unnecessary medicine, while missed dependence, self-harm or unsafe driving leaves preventable risk unaddressed.
A convulsion in the withdrawal window is compatible with alcohol withdrawal, but prevalent competing causes in dependent drinkers make examination and targeted investigation essential.
Hospital toxicology panels detect selected metabolites and can remain positive after intoxication has resolved; clinical toxidromes and NPIS advice are often more actionable.
Alcohol withdrawal is not driven by the usual focal epileptic mechanism, and NICE specifically advises not to offer phenytoin to treat alcohol-withdrawal seizures.
Give thiamine promptly to an at-risk patient, but never allow the search for thiamine or intravenous access to postpone immediate treatment of proven hypoglycaemia.
The label should follow a defensible causal timeline and exclusion of important alternatives; it should not be assigned merely because alcohol or drugs appear in the history.
Assuming that every seizure in a person who drinks heavily is withdrawal and missing subdural haemorrhage, infection, hypoglycaemia or epilepsy.
Using a urine drug screen as proof of which substance caused the seizure or as reassurance that no toxic agent was involved.
Giving repeated sedative doses without respiratory observation in someone who may also have taken alcohol, opioids or other central nervous system depressants.
Prescribing phenytoin for an uncomplicated alcohol-withdrawal seizure instead of treating the withdrawal syndrome and recurrence risk appropriately.
Starting indefinite antiseizure treatment before deciding whether the insult was reversible, while simultaneously omitting safety and driving advice.
Discharging after one recovered convulsion without planning for later withdrawal severity, recurrent seizures, nutrition, dependence care or deliberate-overdose assessment.
Your practice draft is saved in this browser.
A man dependent on alcohol has a brief generalised seizure 18 hours after abruptly stopping drinking. Glucose is normal, he has recovered, and assessment supports uncomplicated withdrawal. Which medication principle is most appropriate?
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.
Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes
Drug-related management is mechanism-led. Immediate supportive care and benzodiazepines treat many toxin-associated convulsions, but refractory events may need critical-care anaesthesia. Isoniazid toxicity requires pyridoxine; sodium-channel blockade from tricyclic antidepressants may require sodium bicarbonate; severe serotonin toxicity needs withdrawal of serotonergic agents, cooling and specialist toxicology care. Activated charcoal is not a reflex response after a seizure because airway protection and timing determine safety. Contact the National Poisons Information Service through TOXBASE or the telephone route available to clinicians, preserve packaging and record formulation, dose, time and co-ingestants. Once stable, decide whether the event was truly acute symptomatic, address dependence or self-harm, and arrange first-seizure or neurology review if diagnostic uncertainty or enduring risk remains.
Repeated doses can cause respiratory depression and oversedation, especially with alcohol, opioids, head injury or liver disease; use monitoring and trained staff.
Give in a setting able to manage rare anaphylaxis; oral absorption is inadequate for suspected Wernicke encephalopathy, and glucose treatment must not be delayed.
This is specialist toxicology treatment; secure adequate stock early, continue resuscitation and do not extrapolate the regimen to unrelated toxin-induced seizures.